- Home
- NCSM vs MNOV Comparison
NCSM vs MNOV Comparison
Compare NCSM & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- MNOV
- Stock Information
- Founded
- NCSM 2006
- MNOV 2000
- Country
- NCSM United States
- MNOV United States
- Employees
- NCSM N/A
- MNOV N/A
- Industry
- NCSM Oilfield Services/Equipment
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- MNOV Health Care
- Exchange
- NCSM Nasdaq
- MNOV Nasdaq
- Market Cap
- NCSM 76.3M
- MNOV 68.2M
- IPO Year
- NCSM 2017
- MNOV 2005
- Fundamental
- Price
- NCSM $34.84
- MNOV $1.31
- Analyst Decision
- NCSM
- MNOV Strong Buy
- Analyst Count
- NCSM 0
- MNOV 2
- Target Price
- NCSM N/A
- MNOV $7.00
- AVG Volume (30 Days)
- NCSM 6.1K
- MNOV 50.0K
- Earning Date
- NCSM 07-31-2025
- MNOV 08-14-2025
- Dividend Yield
- NCSM N/A
- MNOV N/A
- EPS Growth
- NCSM N/A
- MNOV N/A
- EPS
- NCSM 4.71
- MNOV N/A
- Revenue
- NCSM $175,468,000.00
- MNOV $134,599.00
- Revenue This Year
- NCSM $7.17
- MNOV N/A
- Revenue Next Year
- NCSM $5.44
- MNOV N/A
- P/E Ratio
- NCSM $7.40
- MNOV N/A
- Revenue Growth
- NCSM 19.31
- MNOV N/A
- 52 Week Low
- NCSM $16.81
- MNOV $1.13
- 52 Week High
- NCSM $38.95
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- NCSM 63.78
- MNOV 48.44
- Support Level
- NCSM $31.78
- MNOV $1.25
- Resistance Level
- NCSM $34.07
- MNOV $1.40
- Average True Range (ATR)
- NCSM 1.65
- MNOV 0.07
- MACD
- NCSM 0.27
- MNOV -0.01
- Stochastic Oscillator
- NCSM 83.49
- MNOV 24.00
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.